Brief: China Regenerative Medicine International Says Qtrly Revenue Hk$89 Million
08/12/2017 12:58
Dec 8 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* QTRLY REVENUE HK$89 MILLION VERSUS HK$25.5 MILLION
* QTRLY NET LOSS HK$63.3 MILLION VERSUS NET LOSS OF HK$61.8
MLN
Source text for Eikon: urn:newsml:reuters.com:*:nHKSbT9QQM
Further company coverage: 8158.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital